In Vitro Diagnostic (IVD) In Cardiology And Neurology Trends and Opportunities 2025-2034: A Comprehensive Guide to Growth Insights
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Factors Are Driving the Anticipated Growth Rate of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Through 2034?
The market size of in vitro diagnostic (IVD) in the sectors of cardiology and neurology has been on an upward trend in the recent past. The market is predicted to rise from $15.84 billion in 2024 to $17.27 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 9.0%. The growth witnessed during the historic period is attributable to an increase in prevalence of cardiovascular and neurological disorders associated with aging, a rising aging population, and an increased focus on preventive healthcare and early detection of diseases. Other contributing factors include an escalating incidence of cardiovascular and neurological conditions such as stroke and Alzheimer’s disease, increased healthcare infrastructure investment, and supportive regulatory frameworks that govern diagnostic test approval and reimbursement.
There is an anticipation for robust expansion in the in vitro diagnostic (IVD) market related to cardiology and neurology in the coming years. The forecast suggests an escalation to $24.07 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. The propulsion in the growth during this projected period can be linked to the move towards personalized medicine in cardiology and neurology, the rising necessity for quick and local testing solutions in these areas, proliferation of telemedicine and remote consultation services, and an increase in research endeavors. Key upcoming trends for this period encompass the advent of liquid biopsy technologies, breakthroughs in nanotechnology, the integration of remote monitoring devices like implantable cardiac monitors and brain-computer interfaces, application of multiplex biomarker panels, innovations in medical imaging techniques such as MRI, CT, and PET scans, and the evolution of companion diagnostics for cardiovascular and neurological medication.
What Factors Are Propelling the Growth of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market from 2025 to 2034?
The surge in personalized medicine is set to drive the growth of the market for in vitro diagnostics (IVD) in cardiology and neurology. Personalized medicine, which supports healthcare decisions, strategies, interventions and treatments tailored to each patient’s unique characteristics, is growing due to developments in genomics, a deeper understanding of how diseases work, consumer demand for personalized treatments, and regulatory support, among other things. In vitro diagnostic (IVD) tests in the fields of cardiology and neurology play a vital role in promoting personalized medicine, offering key insights into a person’s genetic makeup and disease condition, therefore enabling the creation of customized treatment protocols for better effectiveness and decreased risks. For example, the Personalized Medicine Coalition, a professional membership group based in the United States, reported that in 2022, the approval of 12 new personalized medicines amounted to about 34% of all new therapy approvals, signifying a significant upward trend compared to previous years. Consequently, the growth in the number of personalized medicines is promoting the expansion of the in vitro diagnostic (IVD) in cardiology and neurology market.
Get Your Free Sample of the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15829&type=smp
Who Are the Major Industry Leaders Accelerating Growth in the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are:
• F. Hoffmann-La Roche Ltd._x000D_
• Thermo Fisher Scientific Inc._x000D_
• Abbott Laboratories_x000D_
• Danaher Corporation_x000D_
• Siemens Healthineers AG_x000D_
Which Current Trends Are Having the Most Impact on the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
Major firms in the cardiology and neurology sector of in vitro diagnostic (IVD) are capitalizing on AI-powered integrated epigenetic systems for early detection of diseases and risk analysis. These advanced systems use machine learning models and sophisticated biomarker examination methods to augment accuracy and sensitivity in spotting and overseeing cardiovascular diseases. These play a crucial role addressing significant triggers of disease advancement. For example, in February 2023, a US biotechnology firm, Cardio Diagnostics Holdings Inc., introduced PrecisionCHD, an AI-empowered blood test crafted for early detection of coronary heart disease (CHD). By leveraging the company’s inclusive epigenetic-genetic engine, this test assesses CHD risk with the intention of early detection and prevention of the most prevalent type of cardiovascular disease. The new test amalgamates epigenetic and genetic biomarkers with machine-learning algorithms, achieving over 75% sensitivity in both men and women. It associates a patient’s biomarker profile with adjustable risk factors, key inducers of CHD, such as smoking, diabetes, hypertension, and high cholesterol levels. PrecisionCHD poses as a non-invasive alternate to exercise stress tests or angiograms, allowing for blood samples to be taken either at the doctor’s office or at home.
Get Instant Access to the Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Report with Swift Delivery!
What Major Market Segments Define the Scope and Growth of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
The in vitro diagnostic (IVD) in cardiology and neurology market covered in this report is segmented –
1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Technology: Immunoassays, Molecular Diagnostics, Hematology, Other Technologies
3) By End-User: Hospitals, Clinical Laboratories, Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers, Point-Of-Care Devices, Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents, Test Kits, Assay Consumables
3) By Software And Services: Diagnostic Software, Data Management Software, IVD Consulting And Support Services
Which Regions Are Key Players in the Growth of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Elements Shape the Definition of the In Vitro Diagnostic (IVD) In Cardiology And Neurology Market?
In vitro diagnostic (IVD) in cardiology and neurology refers to medical tests performed on samples such as blood, urine, or tissue outside the body to diagnose various cardiovascular and neurological conditions. These tests play a crucial role in early detection, monitoring, and treatment decisions for diseases such as heart disease, stroke, Alzheimer’s disease, and others. It also provides timely diagnostic information, guiding patient management, and improving outcomes in cardiology and neurology.
Browse Through More Similar Reports By The Business Research Company:
Medical Image Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-image-management-global-market-report
Image Guided Surgery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/image-guided-surgery-devices-global-market-report
Artificial Intelligence (AI) Image Recognition Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
